Muscat: Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) has unveiled a groundbreaking advancement in cancer care with the launch of Lutetium-177 (Lu-177) PSMA radionuclide therapy.
This introduction expands its Theranostics Programme, fundamentally reshaping the landscape of oncology treatment nationwide.
